STACEY ROBERTS: Open Payments
NPI 1831656230 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,024 in 105 payments from 24 companies in 2025. Trend: 2023 $69 · 2024 $56 · 2025 $2,024
Food & beverage: $1,984Education: $40
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $342 |
| JAZZ PHARMACEUTICALS INC. | 8 | $304 |
| Axsome Therapeutics, Inc. | 20 | $281 |
| Otsuka America Pharmaceutical, Inc. | 7 | $150 |
| Teva Pharmaceuticals USA, Inc. | 13 | $145 |
| LivaNova USA, Inc. | 1 | $96 |
| Neurocrine BioSciences, Inc. | 4 | $95 |
| Vanda Pharmaceuticals Inc. | 3 | $90 |
| SK Life Science, Inc. | 4 | $89 |
| HARMONY BIOSCIENCES LLC | 2 | $81 |
Products named: XYWAV, QULIPTA, Symbravo, REXULTI, AUSTEDO XR, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, INGREZZA, PONVORY.
Industry payments across IN — which companies pay providers there.
